[
  {
    "ts": "2025-08-26T19:51:03+00:00",
    "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
    "summary": "Health care stocks advanced late Tuesday afternoon with the NYSE Health Care Index rising 0.6% and t",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-195103606.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "d9b2b737-49e9-34dc-963e-30ca6e1a3b9c",
      "content": {
        "id": "d9b2b737-49e9-34dc-963e-30ca6e1a3b9c",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Higher Late Afternoon",
        "description": "",
        "summary": "Health care stocks advanced late Tuesday afternoon with the NYSE Health Care Index rising 0.6% and t",
        "pubDate": "2025-08-26T19:51:03Z",
        "displayTime": "2025-08-26T19:51:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-195103606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-195103606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "ALLR"
            },
            {
              "symbol": "LCTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T14:50:40+00:00",
    "headline": "Stock Market Today: Stocks rise despite Trump threats against Fed, tech regulation",
    "summary": "Stocks soldiered back after two off-putting Truth Social posts from the President",
    "url": "https://www.thestreet.com/investing/stock-market-today-august-26-2025",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "44d579c1-bb12-3e93-82f6-200f693399c7",
      "content": {
        "id": "44d579c1-bb12-3e93-82f6-200f693399c7",
        "contentType": "STORY",
        "title": "Stock Market Today: Stocks rise despite Trump threats against Fed, tech regulation",
        "description": "",
        "summary": "Stocks soldiered back after two off-putting Truth Social posts from the President",
        "pubDate": "2025-08-26T14:50:40Z",
        "displayTime": "2025-08-26T14:50:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/7ee5d1aced9c8fdc4df25c5c33d56625",
          "originalWidth": 1199,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WHgBAkomTJfQo7RBQYaHNg--~B/aD04MDA7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/7ee5d1aced9c8fdc4df25c5c33d56625.cf.webp",
              "width": 1199,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/697wHFuWTCp8M.UHNK06vA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/7ee5d1aced9c8fdc4df25c5c33d56625.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/investing/stock-market-today-august-26-2025",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-stocks-sink-145040776.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BA"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "KDP"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GEV"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "CSCO"
            },
            {
              "symbol": "EBAY"
            },
            {
              "symbol": "BF-B"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "VZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T12:39:32+00:00",
    "headline": "The FDA Extends the Review Deadlines for Two Submissions by Regeneron Pharmaceuticals (REGN)",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued US Stocks According to Wall Street Analysts. On August 20, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the FDA has extended the review deadlines for two regulatory submissions of EYLEA HD Injection 8 mg to the fourth quarter of 2025. The submissions made to the FDA […]",
    "url": "https://finance.yahoo.com/news/fda-extends-review-deadlines-two-123932799.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ca69e021-2a3f-3a86-9706-dab3e0d3a454",
      "content": {
        "id": "ca69e021-2a3f-3a86-9706-dab3e0d3a454",
        "contentType": "STORY",
        "title": "The FDA Extends the Review Deadlines for Two Submissions by Regeneron Pharmaceuticals (REGN)",
        "description": "",
        "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued US Stocks According to Wall Street Analysts. On August 20, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the FDA has extended the review deadlines for two regulatory submissions of EYLEA HD Injection 8 mg to the fourth quarter of 2025. The submissions made to the FDA […]",
        "pubDate": "2025-08-26T12:39:32Z",
        "displayTime": "2025-08-26T12:39:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "The FDA Extends the Review Deadlines for Two Submissions by Regeneron Pharmaceuticals (REGN)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xYTEe3VE6sgZxe9COOwZXw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ku0XeMdDvNCP8FVlwzrrCw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-extends-review-deadlines-two-123932799.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-extends-review-deadlines-two-123932799.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T11:54:00+00:00",
    "headline": "J&J earmarks $2B for Fujifilm’s North Carolina facility",
    "summary": "The 10-year deal will expand the biopharma giant’s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.",
    "url": "https://www.manufacturingdive.com/news/jj-earmarks-2-billion-fujifilm-biotechnologies-holly-springs-north-carolina-facility/758602/",
    "source": "Manufacturing Dive",
    "provider": "yfinance",
    "raw": {
      "id": "52ef3a84-901e-354c-ac1c-7e0309218b56",
      "content": {
        "id": "52ef3a84-901e-354c-ac1c-7e0309218b56",
        "contentType": "STORY",
        "title": "J&J earmarks $2B for Fujifilm’s North Carolina facility",
        "description": "",
        "summary": "The 10-year deal will expand the biopharma giant’s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.",
        "pubDate": "2025-08-26T11:54:00Z",
        "displayTime": "2025-08-26T11:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/manufacturing_dive_692/a192d3507bbe304ec597e5f40e17578c",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Fujifilm Biotechnologies' facility is under construction in Holly Springs, North Carolina. Johnson & Johnson has agreed to invest $2 billion to expand its manufacturing capacity at the Fujifilm location.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ERy5nHbdUdDPElyFrTYj.Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/manufacturing_dive_692/a192d3507bbe304ec597e5f40e17578c.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DnmjuwrTNIrr0X7ppJVMUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/manufacturing_dive_692/a192d3507bbe304ec597e5f40e17578c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Manufacturing Dive",
          "url": "https://www.manufacturingdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.manufacturingdive.com/news/jj-earmarks-2-billion-fujifilm-biotechnologies-holly-springs-north-carolina-facility/758602/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-earmarks-2b-fujifilm-115400834.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T11:00:00+00:00",
    "headline": "Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis",
    "summary": "Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) total score U.S. regulatory submission for cemdisiran monotherapy is planned for the first quarter of 2026, pending discussions with the FDA TARRYTOWN, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the primary and key seco",
    "url": "https://finance.yahoo.com/news/regeneron-announces-positive-results-phase-110000311.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d0f8f890-7ecb-38bc-be7f-8f34279aa750",
      "content": {
        "id": "d0f8f890-7ecb-38bc-be7f-8f34279aa750",
        "contentType": "STORY",
        "title": "Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis",
        "description": "",
        "summary": "Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) total score U.S. regulatory submission for cemdisiran monotherapy is planned for the first quarter of 2026, pending discussions with the FDA TARRYTOWN, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the primary and key seco",
        "pubDate": "2025-08-26T11:00:00Z",
        "displayTime": "2025-08-26T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142",
          "originalWidth": 800,
          "originalHeight": 126,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ohIVokMiKClSVTQVwyB2lw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 800,
              "height": 126,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YuYzNeQcIK6rRYN1HdT6UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-announces-positive-results-phase-110000311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-announces-positive-results-phase-110000311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T10:09:54+00:00",
    "headline": "Can Regeneron’s Value Shine Through After Recent Stock Slump in 2025?",
    "summary": "If you’re wondering what to do with Regeneron Pharmaceuticals stock right now, you’re not alone. It’s easy to feel torn when a company has a track record of innovation and a share price that’s been on a roller coaster. Over the past year, Regeneron investors have seen some ups and a lot of downs, with the share price dropping more than 52.1% in the last twelve months and ending last week down 0.3%. While there was a brief 1.6% boost over the past month, it hasn’t been enough to reverse a...",
    "url": "https://finance.yahoo.com/news/regeneron-value-shine-recent-stock-100954601.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f4dd5a9b-a44e-3648-a521-455d31aa3fac",
      "content": {
        "id": "f4dd5a9b-a44e-3648-a521-455d31aa3fac",
        "contentType": "STORY",
        "title": "Can Regeneron’s Value Shine Through After Recent Stock Slump in 2025?",
        "description": "",
        "summary": "If you’re wondering what to do with Regeneron Pharmaceuticals stock right now, you’re not alone. It’s easy to feel torn when a company has a track record of innovation and a share price that’s been on a roller coaster. Over the past year, Regeneron investors have seen some ups and a lot of downs, with the share price dropping more than 52.1% in the last twelve months and ending last week down 0.3%. While there was a brief 1.6% boost over the past month, it hasn’t been enough to reverse a...",
        "pubDate": "2025-08-26T10:09:54Z",
        "displayTime": "2025-08-26T10:09:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-value-shine-recent-stock-100954601.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-value-shine-recent-stock-100954601.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]